158 related articles for article (PubMed ID: 16312356)
1. In vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, and Enterobacteriaceae.
Rossolini GM; Valentini S; Vaiani G; Satta G
J Chemother; 1989 Jul; 1(4 Suppl):173-6. PubMed ID: 16312356
[No Abstract] [Full Text] [Related]
2. Microbiological studies on lomefloxacin--a new quinolone.
Newsom SW; Rowland C
J Chemother; 1989 Jul; 1(4 Suppl):168-9. PubMed ID: 16312354
[No Abstract] [Full Text] [Related]
3. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa.
Rossolini GM; Valentini S; Satta G
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Jones RN
J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
[No Abstract] [Full Text] [Related]
5. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
Azadian BS; Talboys CA; Roberts AP
J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
[No Abstract] [Full Text] [Related]
6. In vitro activity of lomefloxacin (SC-47111) against enterobacteriaceae, enterococci and staphylococci.
Cornaglia G; Ligozzi M; Pelosi E; Canepari P; Fontana R
J Chemother; 1989 Apr; 1(2):84-90. PubMed ID: 2786558
[TBL] [Abstract][Full Text] [Related]
7. Activity of quinolones against gram-positive cocci: mechanisms of drug action and bacterial resistance.
Schmitz FJ; Higgins PG; Mayer S; Fluit AC; Dalhoff A
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):647-59. PubMed ID: 12373497
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of a new difluorinated quinolone: lomefloxacin (SC-47111).
Mattina R; Cocuzza G; Cocuzza CE
J Chemother; 1989 Jul; 1(4 Suppl):159-61. PubMed ID: 16312351
[No Abstract] [Full Text] [Related]
9. Comparative activity of three new fluoroquinolones.
Coll R; Esteve M; Moros M; Parés J; Xicota MA
Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
[No Abstract] [Full Text] [Related]
10. In vitro evaluation of lomefloxacin activity in Colombia.
Trujillo H; Mejia GI; Castrillon L; Gomez C
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of sparfloxacin against selected enterobacteriaceae and pseudomonaceae including Ps. pseudomallei (melioidosis).
Siristonpun Y; Rojnapisarnvong V; Srimuang S; Tanphaichitra D
J Chemother; 1995 Nov; 7 Suppl 4():54-5. PubMed ID: 8904106
[No Abstract] [Full Text] [Related]
12. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
Sader HS; Watters AA; Fritsche TR; Jones RN
BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.
Rustige C; Wiedemann B
Antimicrob Agents Chemother; 1990 Jun; 34(6):1107-11. PubMed ID: 2118324
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens.
Sonstein SA; Dahlgren J
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494
[TBL] [Abstract][Full Text] [Related]
15. In vitro sensitivities of urinary tract pathogens to lomefloxacin and five other antimicrobial agents.
Peddie BA
N Z Med J; 1989 Jun; 102(869):298. PubMed ID: 2733911
[No Abstract] [Full Text] [Related]
16. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates.
Wright DN; Saxon B; Matsen JM
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone (Lomefloxacin) International Surveillance Trial: a report of 30 months of monitoring in vitro activity.
Jones RN
Am J Med; 1992 Apr; 92(4A):52S-57S. PubMed ID: 1316072
[TBL] [Abstract][Full Text] [Related]
18. Preliminary results on the antibacterial and killing activity of lomefloxacin.
Stefani S; Pellegrino MB; Mezzatesta M; Speciale AM; Caccamo F; Russo G; Nicoletti G
J Chemother; 1989 Jul; 1(4 Suppl):170-2. PubMed ID: 16312355
[No Abstract] [Full Text] [Related]
19. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients.
Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH
Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of fluoroquinolones in combination with zidovudine.
Lewin CS; Allen RA; Amyes SG
J Med Microbiol; 1990 Oct; 33(2):127-31. PubMed ID: 2121991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
